Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

About this update from Collegium Pharmaceutical, Inc.

STOUGHTON, Mass. , Aug. 30, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the H.C. Wainwright 26th Annual Global Investment Conference being held in New York, NY from September 9-11, 2024 . Details of the event are as follows:Fireside Chat Date and Time: Monday, September 9, 2024 , at 12:30 p.m. ET The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com A replay of the webcast will be archived on the Company's website for 90 days following the presentation. About Collegium Pharmaceutical, Inc. Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts . For more information, please visit the Company’s website at www.collegiumpharma.com . Investor Contact: Christopher James , M.D. Vice President, Investor Relations [email protected] Media Contact: Marissa Samuels Vice President, Corporate Communications [email protected] Source: Collegium Pharmaceutical, Inc.

View stock analysis, news, and events for Collegium Pharmaceutical, Inc.